Covidien plc Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DUBLIN, Ireland--(BUSINESS WIRE)--In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on August 25, 2014, the Company’s issued share capital, excluding treasury shares, consisted of 451,825,023 ordinary shares, par value US$0.20 per share (the “Ordinary Shares”). The International Securities Identification Number (ISIN) of the Ordinary Shares is IE00B68SQD29.

The Company confirms that, as of the close of business on August 25, 2014, there were outstanding 1,641,995 restricted share units (the “Restricted Share Units”) and 13,391,399 options to purchase Ordinary Shares (the “Share Options”) granted by the Company. Upon vesting, each Restricted Share Unit entitles the holder to receive one Ordinary Share and each Share Option entitles the holder to purchase one Ordinary Share at the applicable exercise price.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC